Holdings in Company

Paris, France and Camberley, UK – 12 March 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 11 March 2021 that, as at 10 March 2021, BlackRock Inc.’s holding in the Company on a voting and capital basis is 2.99% (2,117,183 shares).